ArticleFrontiers in pharmacology2025

Genome-wide CRISPR screen identified NEK6 as a determinant of sensitivity to CDK4/6 inhibitor in endometrial cancer.

Fangfang Jian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.